Literature DB >> 7869116

Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase.

L M Boulanger1, P J Lombroso, A Raghunathan, M J During, P Wahle, J R Naegele.   

Abstract

Regional variations in the expression of a striatal enriched protein tyrosine phosphatase called STEP were studied in the adult rat brain by a combination of immunocytochemistry, lesion studies, Western blotting, and in situ hybridization. Monoclonal antibodies generated against STEP identified multiple polypeptides of M(r) 46, 37, 33 and a doublet of M(r) 64-66 kDa on Western blots. Although the three STEP immunoreactive bands with lower molecular weights were enriched in cytosolic fractions, the 64-66 kDa doublet was enriched in membrane fractions. All of the immunoreactive forms were abundant in the caudate-putamen and were present in lower amounts or were undetectable in other brain regions. In substantia nigra, the M(r) 64-66 kDa doublet was not detected but bands with M(r) 46, 37, and 33 kDa were present. Immunocytochemical and lesion experiments demonstrated that the cytosolic STEP isoforms present in the substantia nigra are in presynaptic axons originating from the projection neurons of the caudate putamen, which innervate this structure. Additional in situ hybridization studies showed that STEP mRNA expression patterns correlate with the patterns of immunocytochemical staining. These findings indicate that there are multiple polypeptide isoforms of STEP enriched in the basal ganglia and related structures which differ in terms of their intracellular locations and functional roles.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869116      PMCID: PMC6577844     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  97 in total

1.  Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.

Authors:  Ana Saavedra; Albert Giralt; Laura Rué; Xavier Xifró; Jian Xu; Zaira Ortega; José J Lucas; Paul J Lombroso; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Authors:  S M Goebel-Goody; E D Wilson-Wallis; S Royston; S M Tagliatela; J R Naegele; P J Lombroso
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

3.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

Review 4.  Dysregulated Src upregulation of NMDA receptor activity: a common link in chronic pain and schizophrenia.

Authors:  Michael W Salter; Graham M Pitcher
Journal:  FEBS J       Date:  2011-12-05       Impact factor: 5.542

5.  Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.

Authors:  Pradeep Kurup; Yongfang Zhang; Jian Xu; Deepa V Venkitaramani; Vahram Haroutunian; Paul Greengard; Angus C Nairn; Paul J Lombroso
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

6.  A STEP forward in neural function and degeneration.

Authors:  Matthew L Baum; Pradeep Kurup; Jian Xu; Paul J Lombroso
Journal:  Commun Integr Biol       Date:  2010-09

7.  Oxidative stress-induced oligomerization inhibits the activity of the non-receptor tyrosine phosphatase STEP61.

Authors:  Ishani Deb; Ranjana Poddar; Surojit Paul
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

8.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

9.  Inhibition of striatal-enriched tyrosine phosphatase 61 in the dorsomedial striatum is sufficient to increased ethanol consumption.

Authors:  Emmanuel Darcq; Sami Ben Hamida; Su Wu; Khanky Phamluong; Viktor Kharazia; Jian Xu; Paul Lombroso; Dorit Ron
Journal:  J Neurochem       Date:  2014-03-27       Impact factor: 5.372

10.  Specific Proteomes of Hippocampal Regions CA2 and CA1 Reveal Proteins Linked to the Unique Physiology of Area CA2.

Authors:  Kyle J Gerber; Eric B Dammer; Duc M Duong; Qiudong Deng; Serena M Dudek; Nicholas T Seyfried; John R Hepler
Journal:  J Proteome Res       Date:  2019-05-14       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.